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Glioblastomaa b s t r a c t
Porous silica nanoparticles (PSiNPs) have long attracted interest in drug delivery research. However,
conventional synthesis methods for sub-100 nm, functionalised PSiNPs typically give poor monodisper-
sity, reproducibility, or involve complex synthetic protocols. We report a facile, reproducible, and
cost-effective one-pot method for the synthesis of cancer targeting and pH responsive PSiNPs in this size
range, without the need for post-synthetic modification. This was achieved by using monodisperse
L-arginine (Arg)/ poly(acrylic acid) (PAA) polyelectrolyte complexes (PECs) as soft templates for silane
hydrolysis and condensation. Highly uniform PSiNPs with tunable size control between 42 and 178 nm
and disordered pore structure (1.1–2.7 nm) were obtained. Both PAA and Arg were retained within the
PSiNPs, which enabled a high doxorubicin hydrochloride (Dox) loading capacity (22% w/w) and a
4-fold increase in drug release under weakly acidic pH compared to physiological pH. The surface
presentation of Arg conferred significantly higher intracellular accumulation of Arg/PAA-PSiNPs in
patient-derived glioblastoma cells compared to non-tumorigenic neural progenitor cells, which effec-





G. Newham, R.K. Mathew, H. Wurdak et al. Journal of Colloid and Interface Science 584 (2021) 669–683This work brings forward new insights for the development of monodisperse PSiNPs with highly desir-
able built-in functionalities for biomedical applications.
 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Porous silica nanoparticles (PSiNPs) are amongst the most
promising vehicles for drug delivery. Made of chemically inert sil-
ica, their biocompatibility, large internal pore volumes, high sur-
face areas, and ease of functionalisation, have long attracted
attention in medical research [1]. Their enhanced degradation by
the increased reactive oxygen species (ROS) levels observed in
the tumour microenvironment further supports their suitability
for chemotherapeutic delivery as shown by the recent approval
of silica-based ‘C dots’ for Phase 2 clinical trials [2,3].
PSiNPs are most commonly synthesised through a modified
Stöber method, a sol–gel process using the surfactant, cetrimo-
nium bromide (CTAB), as a template for the porous structure. Par-
ticle size and morphological control is achieved though varying
reagent concentrations, reaction temperature, and pH. However,
this method does not typically allow the synthesis of highly uni-
form sub-100 nm particles, which are optimal for prolonged blood
circulation, tumour accumulation, and enhanced cell uptake [4,5].
Adaptations of this method have been used to access the sub-
100 nm range, but they often lead to poor monodispersity, poor
reproducibility, or require complex synthetic protocols [6–8]. In
addition, all of these protocols require additional calcination or
chemical extraction steps to remove the templating surfactant to
access the porous structures, modify the chemical properties of
the final products, and possibly reduce toxicity before biological
application.
To achieve efficient drug delivery, there is a strong impetus for
the chemical functionalisation of PSiNPs with cancer targeting
ligands and/or stimuli-responsive moieties for controlled or trig-
gered drug release [9]. However, the current preparation of func-
tionalised PSiNPs typically involves lengthy post-synthetic
modifications with multiple synthesis, purification, and character-
isation steps, significantly increasing the time and cost of synthe-
sis. This in turn greatly decreases the likelihood of their
successful translation into industrial and clinical use. Therefore,
there remains a crucial need for a facile, reproducible, and cost-
effective synthetic method to obtain monodisperse sub-100 nm
PSiNPs with intrinsic cancer targeting and stimuli-responsive drug
release properties without the requirement for further post-
synthetic modifications.
The polyelectrolyte complex (PEC) templated synthesis method
has emerged as a promising strategy for the facile preparation of
various types of nanoparticles suitable for drug delivery or biolog-
ical imaging such as PSiNPs [10,11], CaCO3 [12,13], zeolitic imida-
zolate framework-8 [14], and lanthanide-doped gadolinium oxide
nanoparticles [15]. The mixing of oppositely charged polymers or
charged polymers with small counterions forms PECs whose size,
polydispersity, surface properties, and chemical functionality
may be precisely tuned. PECs formed from poly(acrylic acid)
(PAA) and NH4+ in mixed water–ethanol solvents have been exten-
sively used as templates to give hollow silica nanoparticles
(HSNPs) [16–19]. This method, however, typically leads to large
particle sizes or poor polydispersity. Recently, the superior ability
of divalent cations to crosslink PAA chains and form small,
monodisperse PECs was demonstrated. The use of Mg2+ and Ca2+
to complex with PAA in hollow silica particle synthesis gave both
smaller particle sizes and narrower size distributions compared670to monovalent cations NH4+, K+, and Na+ [20]. However, the PAA
templates within the synthesised HSNPs were easily removed by
rinsing with water during purification, resulting in the loss of
potential functionality. In contrast, the use of polyvalent poly(L-
glutamic acid) with poly(2-(N,N-diethylamino) ethylmethacrylate)
was found to give more stable PEC templates that were retained
after PSiNP synthesis and purification [10]. The hybrid PSiNPs were
shown to permit doxorubicin (Dox) loading and confer pH respon-
sive drug release. Similarly, the post-synthetic retention of PAA
within CaCO3 and zeolitic imidazolate framework-8 nanoparticles
templated from PAA/Ca2+ and PAA/Zn2+, respectively [13,14] has
also afforded a high drug loading capacity and a pH responsive
drug release kinetic. However, for these systems, electron micro-
scope imaging showed that the size distributions of the synthe-
sised nanoparticles remained broad. There is thus a need to
further explore and tailor the use of other PEC combinations to
improve the uniformity and retain the PEC constituents within
the nanoparticles to provide desirable functionalities for biomedi-
cal applications in a facile and cost-effective manner.
In this study, we report a novel one-pot synthesis method to
obtain monodisperse, sub-100 nm PSiNPs with intrinsic cancer tar-
geting, efficient drug loading, and pH responsive drug release
behaviour by exploiting the unique alcohol induced polyelectrolyte
complexation of L-arginine (Arg) and PAA (Scheme 1). The efficacy
of Arg in the formation of PECs and its ability to template the syn-
thesis of PSiNPs is further compared to a second cation, NH4+. The
key motivations behind the choice of Arg and PAA in the PEC tem-
plate are as follows: (1) Cationic Arg is expected to undergo strong
electrostatic interactions with anionic PAA to form highly uniform,
colloidally stable PECs, and act as a basic catalyst for silane miner-
alisation on the Arg/PAA PEC network to yield PSiNPs with high
porosity and surface areas. (2) The retention of both PAA and Arg
within the PSiNPs facilitates efficient anticancer drug loading
through enhanced electrostatic interactions, as well as promoting
acidic pH responsive drug release. (3) Surface presentation of Arg
on the PSiNPs is expected to confer excellent colloidal stability
and cancer targeting capabilities. Due to argininosuccinate syn-
thetase (ASS) deficiencies in many solid cancers such as glioblas-
toma multiforme (GBM), melanoma, and prostate, auxotrophic
tumour cells greatly rely on exogenous Arg to sustain their devel-
opment and progression [21–23]. The Arg transporter, cationic
amino acid transporter-1 (CAT-1), has been found to be overex-
pressed in many malignancies to enhance Arg uptake and accumu-
lation in tumour cells [24]. There is thus significant potential to
improve the delivery of anticancer therapeutics to tumour cells
via Arg functionalisation of nanocarriers. Indeed, Wang et al.
recently demonstrated efficient delivery of Mn2+ and Dox using
Arg-capped manganese silicate nanobubbles to give significant
tumour suppression in a Huh7 xenograft nude mice model [25].
Despite the promising results, this cancer targeting strategy
remains poorly exploited in nanoparticle mediated drug delivery
systems. Herein, we demonstrate excellent control over the size
and dispersity of Arg/PAA PECs and resulting PSiNPs by varying
the concentration of isopropanol, polyelectrolytes, and silanes.
The relationship of the silane volume to PEC template size and
its effect on particle diameter and monodispersity was comprehen-
sively explored. This relationship was further used to modulate the
surface presentation of Arg and hence the efficacy of cancer
Scheme 1. A schematic showing the polyelectrolyte templated synthesis of Arg/PAA-PSiNPs. (A) PAA and Arg are initially dissolved in water, and (B) upon addition of 2-
propanol (IPA), the electrostatically associated PAA and Arg assemble into aqueous PECs in bulk IPA. (C) The PECs act as templates for the hydrolysis and condensation of the
silica precursor triethoxysilane (TEOS) to form hybrid Arg/PAA-PSiNPs with intrinsic PAA and amino acid functionality.
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targeting capabilities and biosafety of the hybrid PSiNPs were suc-
cessfully demonstrated in primary patient-derived GBM cells and
non-tumorigenic neural progenitor cells. This study provides
important insights for the reproducible, scalable, and cost-
effective synthesis of monodisperse, multifunctional PSiNPs
through the judicious choice of polyelectrolyte templates to
achieve cancer targeting and pH-responsive drug delivery to
improve anti-cancer efficacy.2. Experimental section
2.1 Materials
L-arginine and ammonium hydroxide (28–30 wt% NH3 solution
in water) were purchased from Acros Organics. 2-Propanol (IPA; 
99.7%) was purchased from VWR. Poly(acrylic acid) (PAA;
Mw = 1800), 4-[3-(4-Iodophenyl)-2-(4-nitro-phenyl)–2H-5-tetrazo
lio]-1,3-benzene disulfonate (WST-1) reagent, and poly-L-ornithine
were purchased from Sigma-Aldrich. Tetraethoxysilane
(TEOS; 99.9%) was purchased from Alfa Aesar. Fluorescein
isothiocyanate-poly(ethylene glycol) silane (FITC-PEG-silane;
Mw = 5000) was obtained from Nanocs. Pierce BCA Protein Assay
kit, DMEM/F-12 medium with GlutaMAX, neurobasal medium,
B-27 supplement, N2 supplement, and mouse laminin protein
were purchased form Thermo Fisher Scientific. Spectra/Por 7
regenerated cellulose dialysis tubing (1 kDa MWCO) was pur-
chased from Spectrum Chemical. Recombinant human epidermal
growth factors (rhEGF) and basic fibroblast growth factors (bFGF)
were purchased from Bio Techne and doxorubicin HCl (Dox; 95%)
was purchased from Fluorochem Limited. All chemicals were of
analytical grade and used without further purification. Ultrapure
water (Millipore Milli-Q) with 18.2 MX cm resistivity at 25 C
was used in all experiments.2.2 Preparation of polyelectrolyte templates
To study the IPA-induced formation of Arg/PAA PECs, 100 lL of
1.1  101 mM PAA and 295 lL of 8.6  102 mM Arg were first
added to 1605 lL of ultrapure water (2.0 mL final volume). The
solution was dispersed in an ultrasonic bath for 5 min before the
addition of IPA under stirring. The final volume was topped up to
10.0 mL with ultrapure water and left to stir for 1 h at room tem-
perature. To form NH4OH/PAA PECs, the same procedure was fol-
lowed but with an equimolar amount of NH4OH used in place of
Arg. The final pH was 9.0 for both Arg/PAA and NH4OH/PAA PECs.
For the synthesis of PEC templates with varying amounts of PAA,671Arg or NH4OH, the total volume of the aqueous reagents was main-
tained at 2.0 mL and 8.0 mL of IPA was added under stirring.
2.3 Synthesis of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs
For the PSiNP syntheses presented herein, PEC templates were
prepared with 100 lL of 1.1  101 mM PAA and 295 lL of
8.6  102 mM Arg (or 295 mL of 8.6  102 mM NH4OH) in 80%
v/v IPA (10 mL final volume). Subsequently, 20–500 mL of TEOS
was added and the mixture was stirred at room temperature for
24 h. The final product was collected by centrifugation (17,000g
for 1 h) and purified by rinsing thrice with ultrapure water. The
reaction was also scaled up to 250 mL by increasing the volume
of each reagent used by 25-fold using the same synthetic protocol.
FITC-labelled PSiNPs were synthesised by the addition of ~ 0.1 mol
% of FITC-PEG-silane and 1000 mL of TEOS to 250 mL final volume of
the PEC templates in 80% v/v IPA.
2.4 Characterisation of PECs and PSiNPs
The hydrodynamic diameters and zeta-potentials of the PECs
and PSiNPs were determined by dynamic light scattering (DLS)
using the Zetasizer Nano equipped with a He-Ne laser and with
scattered light detected at 173(Malvern Instrument Ltd., Worces-
tershire, UK). Each sample was run thrice with 12 measurements
per run at 25 C and the size and zeta-potential measurements
are reported as the mean ± standard deviation of the three runs.
The morphology of the PSiNPs was characterised using high reso-
lution TEM (FEI Tecnai G2-Spirit) operated at 120 kV accelerating
voltage with a Gatan Ultrascan 4000 CCD camera. Typically, 5 lL
of each sample was pipetted onto a carbon coated copper grid
and allowed to dry at room temperature before imaging. The par-
ticle size distribution was determined from the obtained TEM
images using the ImageJ analysis software. The FITC-labelled
PSiNPs were characterised using UV–vis spectroscopy (Agilent
Cary 5000) and fluorescence spectroscopy (Edinburgh Instruments
F980) where 1 mL of sample was analysed in a quartz cuvette with
10 mm path length. In the collection of the fluorescence spectra,
0.1 mg/mL of FITC-labelled PSiNPs was excited at 488 nm and
the emission counts were accumulated over 3 repeat measure-
ments recorded between 375 and 650 nm at intervals of 0.5 nm
with 1 s dwell time. To analyse the organic content of the PSiNPs,
thermogravimetic analysis (TGA) was performed (Mettler Toledo
TGA/DSC1 Star System). Prior to analysis, the PSiNPs were lyophi-
lised and approximately 20 mg of sample was added to a crucible
of known mass for analysis. Measurements were performed
between 30 and 650 C at a heating rate of 10 C min1 under
nitrogen flow. PAA and Arg were used to obtain reference spectra.
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Nicolet iS10 equipped with the Thermo Scientific Smart iTX ATR
sampling accessory. Spectral data was collected between 650 and
4000 cm1 with a spectral resolution of 2 cm1. Nitrogen gas
adsorption–desorption isotherms were recorded using the
Micromeritics Tristar 3000 at 77 K with a 10 s equilibration inter-
val. Before measurement, the samples were freeze-dried and
degassed under vacuum at 100 C for 4 h. The specific surface area
of the sample was found using the Brunauer–Emmett–Teller (BET)
plot as described by Roquerol et al. in the relative pressure range of
0.02–0.16 [26]. The pore size distribution was determined by non-
local density functional theory (NLDFT) analysis of the adsorption
data in the relative pressure range of 0–0.9 using the Micromeritics
Microactive analysis software.
2.5 Drug loading and release
2 mg of Arg/PAA-PSiNPs or NH4OH/PAA-PSiNPs were suspended
in 1, 2, or 4 mg mL1 of Dox solution (1.0 mL). The mixture was
stirred at room temperature under dark conditions for 48 h. The
Dox-loaded particles were collected by centrifugation (17,000g
for 10 min) and rinsed thrice with ultrapure water to remove
excess drug. To determine the drug loading capacity, the amount
of non-encapsulated drug remaining in the supernatants from each
rinse was determined by UV–vis spectroscopy at 480 nm using a
standard calibration curve prepared from solutions of known Dox
concentrations. The total amount of non-encapsulated drug in
the supernatants was subtracted from the initial amount of drug
added to determine the mass of drug loaded into the particles.
The drug loading capacity was calculated using the following
formula:
Drug loading capacity (%)
¼ ðMassofloadeddrugÞ=ðMassofparticlesÞ  100% ð1Þ
To quantify the drug release rate, 9 mg of dox-loaded Arg/PAA-
PSiNPs or NH4OH/PAA-PSiNPs were suspended in 2.0 mL of water
and transferred to a dialysis bag (1 kDa MWCO). The samples were
dialysed against 50 mL of 1  PBS (pH 7.4) or 239 mM sodium acet-
ate buffer (pH 5.0) with equivalent ionic strengths at 37 C under
magnetic stirring. At regular time points, 1.0 mL of the dialysate
was removed for analysis of Dox concentration and replaced with
fresh buffer. The amount of drug released was quantified using
UV–vis spectroscopy at 480 nm. The drug release kinetics and
mechanisms were evaluated using the Korsmeyer-Peppas model
[27]:
F ¼ kmtn ð2Þ
Where F is the fraction of drug released, km is the kinetic con-
stant dependent on the structural and geometric properties of
the particles, and n is the release exponent which indicates the
drug release mechanism. Data points up to 60% of drug release in
the cumulative release curves were plotted on logarithmic scales,
and the release exponent, n, was found from the gradient. The
value for nwas then substituted into Eq. (2) to find the kinetic con-
stant, km.
2.6 Cell culture
Patient-derived glioblastoma GBM1 and GBM20 cells, which
have been confirmed to retain the histopathological features of
their parent tumours [28,29], were cultured on poly-L-ornithine
and laminin-coated cell culture flasks in neurobasal medium sup-
plemented with 0.5  B-27, 0.5  N-2, 40 ng/mL bFGF, and
40 ng/mL rhEGF. The non-tumourigenic adult brain neural progen-
itor NP1 cells were cultured in DMEM/F-12 medium supplemented672with 0.5  B-27, 0.5  N-2, 20 ng/mL bFGF, and 20 ng/mL rhEGF,
1  GlutaMax-1, and 5% fetal bovine serum. All cells were main-
tained at 37 C with 5% CO2.2.7 Cytotoxicity testing
The cytotoxicity of the empty and Dox-loaded Arg/PAA-PSiNPs
and NH4OH/PAA-PSiNPs was determined using the WST-1 assay.
GBM1, GBM20, and NP1 cells were seeded at a density of 8  103
cells per well in 96-well plates and left to adhere for 24 h. The cell
culture media was replaced with fresh media containing 5–750 mg
mL1 of PSiNPs or Dox-loaded PSiNPs containing 0.01–50 mM of
Dox and incubated for 24 h. After incubation, the cells in each well
were rinsed with PBS, and 100 mL of fresh media containing 10 mL
of WST-1 reagent was added to each well. The cells were then incu-
bated for 2 h at 37 C before the absorbance was determined at
440 nm using a microplate spectrophotometer (Molecular Devices
SpectraMax M2e). Blank wells containing cell culture media and
WST-1 (without cells) were included to determine the background
absorbance. The cell viability of treated cells was determined by
comparison to untreated controls as follows:Cell viability (%)
¼ ½ðATreated—ABackgroundÞ=ðAUntreatedControl—ABackgroundÞ  100%
ð3Þ2.8 Cellular uptake studies
GBM1, GBM20, and NP1 cells were seeded at a density of
8  103 cells per well in 96-well plates and allowed to adhere for
24 h. The cells were incubated with fresh media containing
200 mg mL1 FITC-labelled Arg/PAA-PSiNPs and NH4OH/PAA-
PSiNPs for 4 h before carefully rinsing the cells 5 times with PBS
to remove non-internalised PSiNPs. The cells were lysed with 1%
v/v triton-X100 in PBS and the fluorescence intensity of the lysate
was determined at 420 nm excitation and 518 nm emission wave-
lengths with a microplate spectrophotometer. To determine the
concentration of PSiNPs taken up by the cells, the measured fluo-
rescence intensity was compared to a calibration curve prepared
from known FITC-labelled PSiNP concentrations in the same 1%
v/v triton-X100 solution. The protein content of each well was
determined using the BCA protein quantification assay. 15 mL of
the cell lysate was added to 200 mL of BCA reagent in a 96-well
plate, and incubated at 37 C for 30 min. The absorbance was mea-
sured at 562 nm with a microplate spectrophotometer and com-
pared to a calibration curve prepared from known concentrations
of bovine serum albumin.
For fluorescence imaging, cells were seeded onto 8-well cham-
ber slides and treated with 200 mg mL1 of FITC-labelled Arg/PAA-
PSiNPs and NH4OH/PAA-PSiNPs. After 4 h incubation, the cells
were rinsed 5 times with PBS and transferred to heated stage at
37 C for imaging using a confocal laser scanning microscope (Leica
DMi8/SP8).2.9 Statistical analysis
Results obtained from cell uptake experiments were analysed
using the two-tailed Student’s t-test to determine statistical signif-
icance. Differences between treatment groups were considered to
be statistically significant when P < 0.05.
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3.1. Effect of isopropanol/water volume ratio on the formation and size
of Arg/PAA polyelectrolyte droplets
In this study, oppositely charged PAA and Arg were first mixed
in water at a molar ratio of 1:230 before the addition of IPA to
induce formation of aqueous PEC droplets, which act as templates
for the subsequent hydrolysis and condensation of silanes
(Scheme 1). The influence of increasing the IPA volume on the for-
mation and stability of the PECs was first investigated using
dynamic light scattering (DLS) [30]. The correlation function curve,
which is a plot of the intensity signal autocorrelation over a very
short time scale, provides important information on the size and
polydispersity of a particle suspension undergoing Brownian
motion. To monitor colloid formation, the correlation function
curves of Arg/PAA, NH4OH/PAA, and PAA formed under different
IPA volume fractions were collected. Figure S1 shows that for each
PEC or PAA, a critical IPA volume is required for the formation of a
stable particle suspension, which is characterised by a smooth, sin-
gle exponential decay of the correlation function curve. For ease of
interpreting the relationship and to explain the mechanisms
involved in the IPA-induced colloid formation and stabilisation, a
plot of the correlation function y-intercept against the IPA to water
volume fraction is presented (Fig. 1A). The correlation function
y-intercept gives an indication of the signal-to-noise ratio of the
sample. A value closer to 1 indicates that the signal from a mea-
sured sample is high and taken together with the smooth exponen-
tial decays seen in correlation function curves shown in Figure S1,
signifies that stable particles were formed. As seen from Fig. 1A,
the correlation function y-intercepts of the Arg/PAA PECs remained
approximately constant between 0.62 and 0.72 when the IPA vol-
ume fraction was increased from 0 to 50%. From 60 to 80% v/v
IPA, a marked increase of the correlation function y-interceptFig. 1. Isopropanol (IPA)-induced formation and stabilisation of soluble polyelectrolyte
correlation function y-intercepts of Arg/PAA, NH4OH/PAA, and PAA as a function of IPA vo
Arg/PAA, (C) NH4OH/PAA, and (D) PAA droplets formed at the critical range of IPA/wate
673to ~ 0.97 was observed, indicating that PECs with much greater sta-
bility were formed. A further increase in IPA to > 80% v/v resulted
in the precipitation of the PECs. The complexation of the basic
amino acid, Arg, with a polyanion such as polyoxometalates has
been reported to occur via electrostatic interactions with the
guanidinium group of Arg and salt-bridged hydrogen bonds
between the a-NH3+ and a-COO of adjacent Arg molecules
[31,32]. Due to the presence of excess Arg (acrylic acid monomer
to Arg stoichiometric ratio = 1 : 9), the charged stabilised PECs
are expected to be highly water soluble, with low solubility in
IPA. As the dielectric constant of the binary mixture decreases with
increasing IPA volume fractions [33], the electrostatic interaction
parameter, which contributes to the solution free energy for the
oppositely charged Arg and PAA, is enhanced as it is inversely pro-
portional to e3/2 [34,35]. This effectively promotes liquid–liquid
phase separation of aqueous Arg/PAA PEC droplets which are stable
and exist in equilibrium with the supernatant phase at a critical
IPA volume of 60%.
A similar trend was observed with NH4OH and PAA in which
stable NH4OH/PAA PECs were formed only between 80 and 99%
v/v IPA (Fig. 1A and S1B). The lower IPA volume required to induce
Arg/PAA PEC formation could be attributed to the higher cationic
charge density of Arg and its ability to act as a crosslinker between
anionic PAA chains, thus giving rise to stronger electrostatic inter-
actions within the PEC. It is also worth noting that Arg/PAA PECs
had higher correlation function y-intercept values than the 0.23–
0.56 seen for NH4OH/PAA at all concentrations below the critical
IPA volumes, hence demonstrating that the Arg/PAA PECs formed
were more stable. The behaviour of PAA alone with varying IPA/
water volume fractions was also evaluated for comparison. Unlike
the Arg/PAA and NH4OH/PAA PEC systems, PAA undergoes liquid–
liquid phase separation to form single component particles at
much lower IPA volumes of 30–50% v/v (Fig. 1A and S1C). This phe-
nomenon is due to a different mechanism in which the solubilitycomplexes and PAA droplets. (A) Changes in the dynamic light scattering measured
lume and dielectric constant[37]. Intensity weighted size distributions of stable (B)
r volume fractions corresponding to the coloured boxes shown in (A).
Fig. 2. Changes in the dynamic light scattering measured hydrodynamic diameters
and polydispersity index of PECs formed by varying (A) Arg with PAA fixed at
111 mM, and (B) varying PAA with Arg fixed at 25.4 mM in 80% v/v IPA.
Table 1
pH values of PEC mixtures prepared with 2.0–30.8 mM of Arg or NH4OH with a fixed
111 mM of PAA in 80% v/v solution of IPA in water.
Arg or NH4OH
concentration (mM)
pH of Arg/PAA PEC
mixtures
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ity due to the complexation of the added IPA with water molecules
[36]. Whilst PAA is separately soluble in water and IPA, its solubil-
ity is affected in the mixture. Initially, the PAA chains were ionised
in water and were fully solvated due to hydrogen bonding with
water. However, as more water/IPA complexes formed with the
addition of increasing IPA volumes (0–30% v/v), PAA gradually
becomes desolvated due to the reduced availability of free water
molecules. This resulted in the stepwise increase in the signal-to-
noise ratio or correlation function y-intercept observed (Fig. 1A).
Despite the formation of water/IPA complexes, the water mole-
cules remained in excess to solubilise the PAA chains. At a critical
IPA range (30–50% v/v), the mixture is composed almost entirely of
water/IPA complexes which are a poor solvent for PAA. The PAA
droplets were thus the most stable with correlation function y-
intercepts of > 0.8 and smooth correlation function curves
obtained. Above this concentration, all the water molecules were
sequestered within the water/IPA complexes and any additional
IPA exists simply in bulk and is thus able to re-solubilise the PAA
chains through enhanced hydrogen bonding. This results in the
dissolution of PAA droplets and a decrease in the correlation func-
tion y-intercepts to baseline levels (~0.3) above 80% v/v IPA.
The size distributions of stable droplets obtained at the critical
IPA volumes were further evaluated. As seen from Fig. 1B,
monodisperse Arg/PAA PECs with hydrodynamic diameters of
113.7 ± 2.5 nm (polydispersity index, PDI = 0.03) and 76.6 ± 1.4 n
m (PDI = 0.01) were obtained at 60 and 80% v/v IPA, respectively.
This result contrasts favourably with the NH4OH/PAA PECs, which
had considerably broader size distributions with hydrodynamic
diameters of 103.2 ± 0.83 nm (PDI = 0.23) and 121.9 ± 2.5 nm
(PDI = 0.13) at 80 and 99% v/v IPA, respectively (Fig. 1C). As 80%
v/v IPA yields stable PECs with comparable sizes in both Arg/PAA
and NH4OH/PAA, this solvent condition was selected for subse-
quent experiments investigating PEC size control and their use as
templates for PSiNP synthesis. Although stable, narrowly dispersed
colloids with hydrodynamic diameters ranging from 194 to
273 nm (PDIs of 0.04–0.11) were observed with PAA (Fig. 1D),
the low pH of the reaction mixture renders the colloidal system
unsuitable for use as templates for PSiNP synthesis (to be discussed
in Section 2.3).
3.2. Effect of varying Arg, NH4OH, and PAA on the size and dispersity of
Arg/PAA and NH4OH/PAA templates
As will be seen later, the size of the polyelectrolyte templates
greatly affects the physicochemical and cancer cell targeting prop-
erties of the resultant PSiNPs. As such, we next investigated the
influence of varying Arg, NH4OH, and PAA on the size of the PEC
colloidal templates. By keeping the PAA concentration constant,
an increase in Arg from 2.0 to 30.8 mM led to an increment of
Arg/PAA PEC sizes from 38.5 ± 0.1 to 72.0 ± 1.6 nm; with PDI
remaining below 0.05 (Fig. 2A). As a corresponding pH rise from
6.5 to 9.5 with Arg addition was observed (Table 1), the greater
deprotonation of carboxyl groups in PAA (pKa 4.5) [38] could have
led to increased electrostatic interactions and sequestration of Arg
as it is being added. The ability of Arg to crosslink adjacent PAA
chains via electrostatic interactions and salt-bridged hydrogen
bonding also further acts to enhance packing of more PAA and
Arg, thereby resulting in the greater PEC diameters observed.
Similarly, increasing NH4OH from 2.0 to 15.5 mM gave an
increase in NH4OH/PAA complex size from 70.3 ± 1.8 to 89.5 ± 0.
3 nm but then followed by a decrease to 56.6 ± 1.0 nm for
30.8 mM NH4OH (Figure S2A). The size distributions of the NH4-
OH/PAA complexes were also significantly broader compared to
the Arg/PAA complexes, with PDI values in excess of 0.24 over
the range of NH4OH tested (Figure S2B). The larger NH4OH/PAA674PEC sizes and PDIs observed could be attributed to the lower
charge density of NH4OH and absence of crosslinking ability com-
pared to Arg. This effectively leads to diminished electrostatic
interactions between NH4OH and PAA, thus causing the PECs
formed to be less stable and loosely packed. The resultant PECs
thus have larger diameters and polydispersities.
The effect of varying PAA on the Arg/PAA template size was next
investigated. PAA was found to have a greater influence on the size
of the PECs formed at a fixed Arg concentration of 25.4 mM. As
seen from Fig. 2B, increasing PAA concentration from 25 to
400 mM led to a greater diameter increase from 50 to 130 nm for
the Arg/PAA PECs. The bigger size increase seen with varying PAA
content could be due to the enhanced packing of PAA chains, which
have much larger molecular weights than Arg, within the PECs.
This finding is in agreement with the work by Nakashima et al. in
which increased PAA/NH4+ aggregate sizes with increasing PAA con-
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tantly, the low PDI values ranging from 0.02 to 0.05 were main-
tained through the significant size increase, hence presenting an
efficient means to provide larger monodisperse colloidal templates
for accessing larger functionalised PSiNPs.
3.3. Template directed porous silica nanoparticle synthesis
Upon identification of the optimal condition that leads to the
formation of monodisperse PEC droplets, the Arg/PAA PECs were
next investigated as colloidal templates for the hydrolysis and con-
densation of silanes to yield multifunctional PSiNPs. It was found
previously that increasing Arg from 7.7 to 30.8 mM led to a pH
increase in the reaction mixture from 7.25 to 9.5 (Table 1). As
silane hydrolysis, condensation, and depolymerisation rates are
higher at alkaline pH [39], we first evaluated the influence of Arg
content, and hence the pH of the reaction mixture on PSiNP forma-
tion. TEM images of Arg/PAA-PSiNPs formed at a near neutral pH of
7.25 revealed that small, poorly defined clusters in addition to a
dominant population of PSiNPs with an average diameter of
26 ± 3 nm were formed (Figure S3), suggesting the incomplete
reaction of silica precursors within the 24 h reaction period. In con-
trast, single PSiNP populations ranging from 36 ± 3 to 50 ± 5 nm in
diameter were obtained at a more alkaline pH of 8.0–9.5. To ensure
complete reaction of the silanes and thus greater reproducibility,
all further syntheses were performed at pH 9.0 with 25.4 mM of
Arg.
The effect of varying the volume of the silica precursor tri-
ethoxysilane (TEOS) added to ~ 73 nm (by DLS) Arg/PAA PEC tem-
plates on the final PSiNP size and zeta-potential was subsequently
studied. In general, an increase in TEOS volume from 20 to 500 mL
led to a progressive increase in the size of the Arg/PAA-PSiNPs
obtained (Fig. 3A). When 20 mL TEOS was added, Arg/PAA-PSiNPs
with Z-average diameter of 61.3 ± 0.2 nm were obtained. This cor-
responded to approximately 85% of the original template diameter.
The further addition of TEOS resulted in an overgrowth effect in
which the size of the Arg/PAA-PSiNPs obtained exceeded the tem-
plate size. For instance, at the highest TEOS volume of 500 mL, the
PSiNPs obtained had a diameter of 255.6 ± 3.5 nm, which was 350%
larger than the original PEC template diameter. The overgrowth of
the PSiNPs beyond the PEC template diameter elicited a significant
stepwise increase in PDIs from 0.05 to 0.17 (Fig. 3B). Consistent
with the DLS results, TEM images confirmed that highly uniform
and spherical Arg/PAA-PSiNPs with average diameters between
42 and 100 nm and with standard deviations of < 10% were
obtained when 20–200 mL TEOS were added (Fig. 3C-E). The addi-
tion of 500 mL TEOS resulted in the largest PSiNPs with a size of
178 nm and with a standard deviation increase to 15%. These
results clearly demonstrate the relationship between the colloidal
template size and the amount of silane added on the size and uni-
formity of the Arg/PAA PEC templated PSiNPs obtained. A similar
observation has also been made by Hu et al. where silica over-
growth brought about by an increase in silane mineralisation time
with PAA/poly(L-lysine) PECs led to the formation of more dis-
persed silica nanoparticles with a loss of spherical morphology
[11].
The zeta-potential of the Arg/PAA-PSiNPs in PBS (pH 7.4) was
27.9 ± 1.9 mV at 85% diameter of the colloidal template
(Fig. 3B). This is likely due to the decoration of the PSiNP surface
with Arg whose guanidinium and a-amino groups (pKa 12.1 and
9.0 respectively) [40] have positive charges, and PAA whose depro-
tonated carboxyl groups (pKa 4.5) impart a strongly negative sur-
face charge [40,41]. PAA, however, extends from the surface like
a brush partially covering the surface bound Arg and thus con-
tributes more strongly to the zeta-potential under this growth
regime (Scheme 2). The zeta potential increased to 7.0 ± 0.3 mV675at 200% overgrowth. This result suggests a reduced surface presen-
tation of the negatively charged PAA as the silica network filled the
colloidal templates, although the Arg surface capping of the PSiNPs
was retained due to the large excess of Arg present in the amino
acid catalysed silica synthesis [42]. However, at the maximum
TEOS volume of 500 mL which gave a PSiNP/template diameter
ratio of 350%, a drastic drop in zeta-potential to 42.4 ± 2.0 mV
was observed, suggesting that the particle surface was mainly
comprised of deprotonated silanol groups without the presence
of PAA or Arg. Beyond the addition of a critical amount of TEOS,
the full occupation of the Arg/PAA PECs by the silica and complete
consumption of the individual reagents in the drastically over-
growth regime plausibly led to the loss of surface functionalisation
by these moieties. Taken together, these results demonstrate that
to maintain the desired surface presentation of Arg and PAA on
the PSiNPs, which have important consequences on cellular target-
ing effects, the amount of TEOS added needs to be optimised in
order to obtain a PSiNP diameter that does not significantly exceed
that of the template. Correspondingly, to access larger PSiNPs sizes
that retain their monodispersity and surface functionality, the size
of the Arg/PAA PEC template used could be increased according to
the conditions discussed in section 2.2.
In contrast, the addition of 20–500 mL of TEOS to ~ 100 nm (by
DLS) NH4OH/PAA PECs templates did not give the same effect on
the size and zeta-potential of the resultant PSiNPs obtained (Fig-
ure S4). The smallest TEOS volumes of 20 and 40 mL respectively
gave the largest particles with hydrodynamic diameters of 112
and 153 nm (PDI 0.11 and 0.13) compared to 62 and 97 nm (PDI
0.05 and 0.08) for the Arg/PAA-PSiNPs. This is likely caused by tem-
plate instability and resultant particle coalescence during synthesis
due the inability of NH4+ to efficiently crosslink with PAA during
PEC formation. Contrary also to Arg/PAA-PSiNPs, the TEOS volume
added to the NH4OH/PAA PECs showed no correlation with the
zeta-potentials of the PSiNPs obtained, which were found to be
between 30 to 40 mV independent of the particle growth
regime (Figure S4). As will be seen later, the absence of PAA func-
tionality within the NH4OH/PAA-PSiNPs was confirmed with ATR-
FTIR and TGA, hence the surface charge could be predominantly
attributed to the surface silanol groups. Notably, the zeta-
potential value of the significantly overgrown Arg/PAA-PSiNPs
(PSiNP/template diameter ratio of 350%) is close to the values
obtained for the NH4OH/PAA-PSiNPs, suggesting the lack of surface
PAA or Arg functionality discussed above.
For the successful clinical translation of the Arg/PAA-PSiNPs as
drug carriers, the scalability and reproducibility of the synthesis
are imperative. The simple one-pot synthesis method can be repro-
ducibly scaled-up 25-fold to a 250 mL volume (mass
yield ~ 100 mg) with no detrimental effects to the particle size,
morphology, or monodispersity (Figure S5). The Z-average diame-
ters of the Arg/PAA-PSiNPs obtained from 3 different scaled up
batches were found to have a very small variation of < 5 nm (Fig-
ure S5C). In contrast, PSiNPs synthesised with NH4OH/PAA col-
loidal PEC templates were found to have much poorer size
uniformity and reproducibility with Z-average diameters ranging
from 73 to 151 nm across 3 batches (Figure S6). This could be
explained by the broader size distribution of the NH4OH/PAA PECs
(Fig. 1C), which results in the non-uniform deposition and growth
of porous silica to cause significant size variations between
batches. These results underscore the benefits of using Arg/PAA
PECs as templates for producing highly uniform PSiNPs for
biomedical applications.
3.4. Characterisation of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs
The chemical functional groups of the Arg/PAA-PSiNPs and NH4-
OH/PAA-PSiNPs were characterised by ATR-FTIR and TGA. For both
Fig. 3. (A) Intensity weighted DLS size distributions of the Arg/PAA-PSiNPs displayed in (C-F) with Z-average diameters of 61.3 ± 0.2 nm, 96.9 ± 2.6 nm, 151.6 ± 1.6 nm, and
255.6 ± 3.5 nm synthesised with 20, 40, 200, and 500 mL TEOS respectively. (B) The polydispersity index and zeta-potentials of the Arg/PAA-PSiNPs expressed shown in (A) as a
function of the ratio of the particle and the polyelectrolyte template diameter showing the effect of the under- and over-growth regimes. TEM images and diameter
histograms for Arg/PAA-PSiNPs synthesised by adding (C) 20, (D) 40, (E) 200, and (F) 500 lL of TEOS to 70 nm (by DLS) polyelectrolyte colloidal templates. The average
diameters determined from the TEM images are (C) 42 ± 4 nm, (D) 66 ± 5 nm, (E) 100 ± 9 nm, and (F) 178 ± 28 nm, respectively (n = 200).
Scheme 2. A schematic depiction of the three possible undergrowth and overgrowth regimes and their impact on surface functionality.
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O–Si asymmetric stretching as well as Si–O and Si–OH stretching
were observed at 1000–1250, 794, and 935 cm1, respectively
(Fig. 4A) [43]. The presence of Arg on the Arg/PAA-PSiNP was676confirmed from the presence of common vibrational modes in
the Arg and Arg/PAA-PSiNP spectra. The absorption bands which
correspond to asymmetric –NH– bending, asymmetric –CAO–
stretching, and symmetric –CAO– stretching were observed at
Fig. 4. Chemical characterisation of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs. (A) Stacked ATR-FTIR spectra showing the fingerprint regions for PAA, Arg, Arg/PAA-PSiNP, and
NH4OH/PAA-PSiNP. TGA curves and the 1st derivatives of the weight loss curves for (B) Arg, (C) PAA, (D) Arg/PAA-PSiNPs and (E) NH4OH/PAA-PSiNPs, where coloured peaks
indicate the presence of a common organic compound between samples.
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1679, 1555, and 1474 cm1 for Arg/PAA-PSiNPs. Although the in-
plane –CAOAH bending, asymmetric CH2 stretching, and C@O
stretching modes typical of PAA appeared at 1413, 1450, and
1698 cm1 in the Arg/PAA spectra, they also coincide with peaks
assigned to Arg [45]. Furthermore, broad peaks for the CH2 rocking
and CAO symmetric stretching occurring at 792 and 918 cm1 for
PAA also coincide with the sharper peaks for Si–O and Si–OH
stretching, thus preventing conclusive confirmation of PAA func-
tionalisation in the PSiNPs using ATR-FTIR. As such, TGA was fur-
ther employed as a complementary technique to confirm the677presence of PAA. The absorption spectrum for NH4OH/PAA-
PSiNPs showed comparatively fewer spectral features. As expected,
none of the peaks attributed to Arg were present and the above dis-
cussed in-plane –CAOAH bending, asymmetric CH2 stretching, and
C@O stretching for PAA peaks were also not observed, hence indi-
cating the absence of both Arg and PAA functionality on the NH4-
OH/PAA-PSiNPs. TGA analyses further confirmed the retention of
PAA and Arg functionality within Arg/PAA-PSiNPs whereas no
detectable organic functionality was observed for NH4OH/PAA-
PSiNPs. The thermal degradation profile of Arg/PAA-PSiNPs
revealed distinct weight loss peaks beginning at 229 and 316 C
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thus indicating the presence of Arg within the PSiNPs. The exis-
tence of PAA within the Arg/PAA-PSiNPs was confirmed through
the appearance of a weight loss peak at around 157 C which
was close to that observed at 149 C for PAA alone (Fig. 4C and
D). Consistent with the ATR-FTIR data, no discernible weight loss
ascribed to the presence of PAA was found with the NH4OH/PAA-
PSiNPs (Fig. 4E). It is thus evident that electrostatic interactions
between NH4+ and PAA were not sufficient to retain the polymer
during the repeated washing steps used to remove excess reagents.
Wan and Yu. have also previously reported a similar result in
which PAA was found to be completely removed from hollow silica
nanoparticles templated from PAA/NH4+ in ethanol solutions by
washing [16]. Conversely, the increased charge density and effi-
cient crosslinking ability of Arg enhances packing and retention
of PAA in the PECs and the final PSiNP product, which will be seen
later to contribute greatly to the increased porosity and pH respon-
sive drug release capabilities of the Arg/PAA-PSiNPs.
To determine the surface area and porosity of the Arg/PAA-
PSiNPs and NH4OH/PAA-PSiNPs, N2 adsorption–desorption mea-
surements was performed. From Fig. 5A, the N2 adsorption–des-
orption isotherms of both types of PSiNPs displayed a
characteristic type IV behaviour, with the presence of type H3 hys-
teresis loops which indicates the presence of porous structures.
The surface area of Arg/PAA-PSiNP determined using BET analysis
was found to be 548.7 m2/g. Pore size distributions of the Arg/
PAA-PSiNPs determined using NLDFT analysis showed pore diam-
eters ranging from 1.1 to 2.7 nm, with a dominant peak at
1.8 nm, clearly demonstrating the presence of disordered pore
structures (Fig. 5B). The corresponding data for NH4OH/PAA-
PSiNP displayed pore distributions over a comparable diameter
size range, but with significantly reduced pore volumes, and a
lower BET surface area of 117.5 m2/g. As previously discussed,
the increased charge density and crosslinking ability of Arg leads
to greater retention of PAA chains during the hydrolysis and con-
densation of silane species and the presence of this polyelectrolyte
network gives rise to the particle porosity. This is consistent with
the reduced electrostatic interaction between NH4OH and PAA
and the resulting poor polymer retention within the PECs which
ultimately leads to reduced surface area and porosity for NH4OH/
PAA-PSiNPs.
The colloidal stability of the Arg/PAA-PSiNPs were evaluated in
water, PBS (pH 7.4), and cell culture media by DLS. As seen in Fig-
ure S7, no significant changes in the Z-average diameters and size
distributions were observed in different physiologically relevant
conditions, thus demonstrating their excellent colloidal stability.Fig. 5. (A) N2 gas adsorption/desorption isotherms collected at 77 K for Arg/PAA-PS
determined using non-local density function theory analysis.
6783.5. Drug loading and release of doxorubicin hydrochloride
The drug loading and pH responsive drug release capabilities of
the polyelectrolyte templated PSiNPs were investigated using Dox.
The Arg/PAA-PSiNPs were found to have significantly higher drug
loading capacity compared to the NH4OH/PAA-PSiNPs at 1 and
2 mg/mL initial Dox loading concentrations (Fig. 6A; P < 0.05). With
the Arg/PAA-PSiNPs, the highest drug loading capacity of 22% w/w
was achieved at 1 mg/mL of initial Dox, which is comparable to
that achieved with other porous silica nanoparticles [46–50].
Although several examples of polymer grafted porous silica parti-
cles have exhibited higher loading capacities sometimes in excess
of 50%, this is likely due to interaction of Dox and with exterior
polymer chains which reduces the possibility for adding targeting
or secondary surface functionality [51–53]. A stepwise reduction in
drug loading capacity to 16 and 8% w/w at higher Dox concentra-
tions of 2 and 4 mg/mL, respectively was also observed. In contrast,
the NH4OH/PAA-PSiNPs showed a maximum drug loading capacity
of only 8% w/w at 1 mg/mL Dox. The higher drug loading capacity
of the Arg/PAA-PSiNPs could be attributed to the higher anionic
PAA retention afforded by the presence of Arg within the PECs as
confirmed earlier by TGA (Fig. 4D). This permits enhanced electro-
static interaction with the cationic Dox to give higher drug encap-
sulation capacity within the pores of the Arg/PAA-PSiNPs. The
hydrodynamic diameters of the Dox-loaded Arg/PAA-PSiNPs and
NH4OH-PSiNPs were found to be 162.4 ± 3.4 and 152.2 ± 0.2 nm,
respectively, which were higher than the initial 128.4 ± 2.4 and
132.1 ± 0.1 nm of the respective empty PSiNPs (Figure S8A). This
result suggests that some amount of cationic Dox was also
adsorbed on the surface of the anionic PSiNPs via electrostatic
interactions with surface silanol groups and PAA. Indeed, the
Dox-loaded Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs were found
to have zeta-potentials of 16.0 ± 0.7 and 19.0 ± 0.9 mV, respec-
tively, which were higher than the 24.6 ± 1.1 and 36.9 ± 4.8 mV
observed for empty PSiNPs (Figure S8B), hence indicating the pres-
ence of positively charged Dox on the surface. A significantly
higher drug loading was observed with the Arg/PAA-PSiNPs com-
pared to the NH4OH/PAA-PSiNPs. In the case of the latter, a signif-
icant proportion of the loaded Dox was likely to have been
adsorbed on the exterior surface, whilst the majority of Dox
retained by Arg/PAA-PSiNPs was contained within the pores with
a smaller amount adsorbed on the surface. This conjecture is sup-
ported by the BET and NLDFT data described earlier in which the
dominant pore size for Arg/PAA-PSiNPs was 1.8 nm. This was suf-
ficiently large for the loading of Dox, which has a maximum diam-
eter of 1.5 nm [53]. The smaller pore volumes and peak poreiNPs and NH4OH/PAA-PSiNPs and (B) the corresponding pore size distributions
Fig. 6. (A) Drug loading capacity of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs (1 mg/mL) incubated with 1, 2, and 4 mg/mL Dox for 48 h. (B) Cumulative Dox release from the
Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs over 48 h in PBS (pH 7.4) and sodium acetate buffer (pH 5.0). The results represent mean ± standard deviation from 3 independent
experiments.
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ing and retention of drug within the pore network compared to the
Arg/PAA-PSiNPs.
An added benefit of incorporating PAA within the colloidal tem-
plates used for the synthesis of PSiNPs is the ability to provide
stimuli-responsive drug release in response to an acidic tumour
microenvironment and/or endosomal environment following cel-
lular uptake. As the carboxylic acid groups in PAA have a pKa of
4.5, they are predominantly deprotonated at the physiological pH
of 7.4, leading to the extension of the polymer chains into the pores
due to electrostatic repulsion. This effectively enhances the inter-
action and retention of the Dox by the extended PAA chains within
the pores of the Arg/PAA-PSiNPs. Under acidic pH, however, the
protonation of PAA’s carboxylic acid groups leads to reduced inter-
action between PAA chains and the Dox, thus facilitating drug
release from the PSiNPs. As depicted in Fig. 6B, the Arg/PAA-
PSiNPs were found to have a significantly higher drug release of
33.3% in sodium acetate buffer (pH 5.0) compared to only 8% in
PBS (pH 7.4) over 48 h. The low levels of Dox released at physiolog-
ical pH could be attributed to charge screening effects by ions in
the PBS to reduce electrostatic interactions between the adsorbed
drug with deprotonated PAA and/or surface silanol groups.
Although a similar pH-responsive Dox release profile was also
observed with the NH4OH/PAA-PSiNPs, it is important to note that
the maximum drug release attained at pH 5.0 was much lower at
17.4%. The enhanced Dox release from the NH4OH/PAA-PSiNPs
under acidic pH is likely to be due to the fact that most of the
Dox molecules were adsorbed on the surface through electrostatic
interaction with surface silanol groups (pKa 4.5) [54], and thus a
decrease in pH to 5.0 leads to the partial protonation of the silanol
groups and Dox displacement from the surface of the PSiNPs. The
absence of PAA in the NH4OH/PAA-PSiNPs was confirmed earlier
by TGA, thus the mechanism of drug loading and release is ascribed
to electrostatic interactions between the surface silanol groups and
cationic Dox.
The in vitro drug release kinetics and mechanisms at different
pH were further evaluated using the Korsmeyer-Peppas model
[27]. Good linearity with high correlation coefficients (R2) of
> 0.98 were found for all the samples thus indicating the appropri-
ateness of this model for evaluating the drug release kinetics
(Figure S9 and Table 2). As discussed previously, the increased pro-
tonation of PAA chains within the Arg/PAA-PSiNPs with a decrease
in pH from 7.4 to 5.0 leads to greater and faster drug release in
acidic pH. Indeed, a rise in the kinetic constant, km from 1.78 to6796.84 was seen with the Arg/PAA-PSiNPs, hence indicating more
rapid drug release in acidic pH (Table 2). In contrast, a smaller
increase in the km from 1.05 to 3.11 was observed for the NH4-
OH/PAA-PSiNPs with pH reduction (Table 2). This result indicates
that a slower rate of drug release from the NH4OH/PAA-PSiNPs is
occurring in acidic pH possibly via the pH-dependent displacement
of surface adsorbed Dox. The release exponent, n, was found to
range from 0.58 to 0.73 for all samples, hence indicating that the
drug release from the Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs
occurred by non-Fickian diffusion (n > 0.43) involving both diffu-
sion and polymer swelling. Although PAA was only detected in
the Arg/PAA-PSiNPs and not in the NH4OH/PAA-PSiNPs (Fig. 4),
the similar n values observed for both particle types at the same
pH suggest a diffusion mechanism that is dependent on pH and
electrostatic interactions (Table 2).
3.6. In vitro biosafety and selective uptake of Arg/PAA-PSiNPs by
primary human glioblastoma cells
The biosafety and uptake of the Arg/PAA-PSiNPs and NH4OH/
PAA-PSiNPs were assessed using two different patient-derived
GBM cell lines, GBM1 and GBM20. The GBM1 cell line was derived
from a primary tumour with no prior treatment and the GBM20
cell line originated from recurrent GBM post radiotherapy, temo-
zolomide, and IMA950 treatment [28,29]. Both cell models exhibit
stem cell-like features as well as transcriptional heterogeneity at
the single cell level representing classical, proneural, and mes-
enchymal GBM tumour cell subpopulations. In addition, the non-
tumorigenic human adult neural progenitor cell line, NP1, derived
from primary tissue obtained from a patient undergoing epileptic
surgery, was included as a control [28,29]. The cytotoxicity of the
Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs towards the various cell
lines was first evaluated using the WST-1 assay. No significant
cytotoxicity was observed in GBM1 and NP1, with > 80% cell viabil-
ity observed up to high concentrations of 750 mg/mL after 24 h
treatment (Fig. 7A and C). Although a slight dose-dependent toxic-
ity was observed in GBM20, the cell viability remained  77% up to
a supraphysiological concentration of 250 mg/mL, which was much
higher than the concentrations used in subsequent cellular uptake
and drug delivery studies. As Arg/PAA-PSiNPs and NH4OH/PAA-
PSiNPs have similar cytotoxicity profiles in GBM20 at high concen-
trations, it is likely that the induced cyctotoxicity observed is
intrinsic of silica nanoparticles and is not due to the added Arg
or PAA surface functionality.
Table 2
The release exponent, n, and kinetic constant, km, describing the pH responsive release kinetics, and R2 values for Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs.
Particle type pH of release medium n km R2
Arg/PAA-PSiNPs 5 0.73 ± 0.04 6.84 ± 0.08 0.996
7.4 0.58 ± 0.01 1.78 ± 0.01 0.999
NH4OH/PAA-PSiNPs 5 0.72 ± 0.06 3.11 ± 0.07 0.988
7.4 0.61 ± 0.01 1.05 ± 0.03 0.981
Fig. 7. Cytotoxicity of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs in patient-derived glioblastoma cell lines. Graphs show cellular viability of GBM1 (A), GBM20 (B), and the (C)
non-tumourigenic human adult neural progenitor NP1 cells treated with 0–750 mg/mL of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs for 24 h. The results represent
mean ± standard deviation from at least 2 independent experiments performed with six replicates.
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Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs were synthesised by the
co-condensation of FITC-PEG-silane with TEOS. By varying the vol-
ume of silanes added, the diameters of the FITC-labelled Arg/PAA-
PSiNPs were readily tuned between 22.8 ± 2.3 nm–83.9 ± 9.7 nm;
with narrow size distributions obtained (Figure S10A-C). The FITC-
labelled Arg/PAA-PSiNPs demonstrated strong absorbance at
490 nm, with a clear fluorescence emission peak at 518 nm with
excitation at 490 nm (Figure S10D-E). GBM1, GBM20, and NP1 cells
were incubated with FITC-labelled Arg/PAA-PSiNPs and NH4OH/
PAA-PSiNPs with comparable Z-average diameters of 112.9 ± 2.2
and 127.6 ± 2.6 nm, respectively for 24 h. After removal of non-
internalised PSiNPs, the cells were lysed and quantified for cellular
uptake using fluorescence spectrometry. To account for differences
in cell number and size between cell lines, the fluorescence inten-
sity values obtained were normalised for protein expression deter-
mined by BCA assay. A significantly higher uptake of Arg/PAA-
PSiNPs compared to the non-targeting NH4OH/PAA-PSiNPs was
observed in both GBM cell models (Fig. 8A; P < 0.001); with a
2.9- and 3.7-fold higher uptake of Arg/PAA-PSiNPs in GBM1 and
GBM20, respectively. Notably, there was no significant difference
in uptake of Arg/PAA-PSiNPs and NH4OH/PAA-PSiNPs in the680non-tumourigenic NP1 cells (P > 0.05). To further confirm the cel-
lular internalization of the Arg/PAA-PSiNPs and NH4OH/PAA-
PSiNPs, confocal imaging of the GBM20 and NP1 cells was per-
formed. Consistent with the cellular uptake data, GBM20 cells trea-
ted with the cancer targeting Arg/PAA-PSiNPs exhibited stronger
fluorescence intensities compared to the non-targeting NH4OH/
PAA-PSiNPs and Arg/PAA-PSiNP treated non-tumourigenic NP1
cells (Fig. 8). No apparent difference in fluorescence intensities
between confocal images of NP1 cells treated with Arg/PAA-
PSiNP and NH4OH/PAA-PSiNPs was observed. Z-stack imaging of
the Arg/PAA-PSiNP treated GBM20 cells confirmed that the
nanoparticles were internalised by the cells and were not simply
adhered to the surface of the cells (Movie S1). These results
demonstrate a marked enhancement of cellular uptake capabilities
of the Arg/PAA-PSiNPs towards the GBM cells over non-
tumourigenic NP1 cells, thus demonstrating their potential for
use as selective cancer targeted drug delivery vehicles.
3.7. Effect of Arg/PAA-PSiNP overgrowth on cellular uptake
As discussed earlier, the increased addition of TEOS to the initial
PEC template to obtain significantly overgrown Arg/PAA-PSiNPs
Fig. 8. Enhanced targeting and uptake of Arg/PAA-PSiNPs by patient-derived
glioblastoma cells. (A) Cellular uptake of FITC-labelled Arg/PAA-PSiNPs and NH4OH/
PAA-PSiNPs after treating GBM1, GBM20, and non-tumourigenic neural progenitor
NP1 cells with 200 mg/mL of PSiNPs for 4 h. The fluorescence intensities of the
internalized particles were normalized for cellular protein content using the
bicinchoninic acid assay. Each data point represent mean ± standard deviation from
at least two independent experiments performed with six replicates. *** P < 0.001;
NS indicates lack of statistical significance (P > 0.05). (B) Confocal images of GBM20
and NP1 cells following treatment with FITC-labelled Arg/PSiNPs and NH4OH/PAA-
PSiNPs. (C) Cellular uptake of overgrown FITC-labelled Arg/PAA-PSiNPs and NH4OH/
PAA-PSiNPs by GBM20 cells performed in triplicate.
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in zeta-potential to 42.4 ± 2.0 mV (Fig. 3B), which was indicative
of deprotonated silanol groups at a particle surface devoid of Arg681functionalisation. The cellular uptake of the significantly over-
grown Arg/PAA-PSiNPs was thus further investigated using
GBM20 cells. Compared to the Arg/PAA-PSiNPs synthesised with
40 mL of TEOS (PSiNP/template diameter ratio of 157%) which have
shown tumour specific targeting earlier (Fig. 8A), a significant
decrease in the normalised fluorescent intensity from 933 a.u. to
558 a.u. was seen, thus demonstrating a reduced cellular uptake
of the overgrown Arg/PAA-PSiNPs. Importantly, a direct compar-
ison of the cellular uptake of overgrown Arg/PAA-PSiNPs and NH4-
OH/PAA-PSiNPs with comparable hydrodynamic diameters of
226.3 ± 6.4 and 194.3 ± 2.9 nm, respectively (Figure S11), did not
give a significant difference in cellular uptake (P > 0.05; Fig. 8C).
This result clearly indicates a loss of cancer targeting abilities when
Arg/PAA-PSiNPs were prepared in a drastically overgrown regime
from the initial PEC colloid template. When small amounts of TEOS
were added, sufficient Arg and PAA remained available within the
colloidal system to present on the surfaces of the Arg/PAA-PSiNPs
formed. Beyond the addition of a critical amount of TEOS, most
of the Arg and PAA in the system were likely to have been used
up as scaffolds for the hydrolysis and condensation of the silanes,
hence resulting in the formation of PSiNPs with minimal or no
Arg surface functionalisation for cancer targeting (Scheme 2).
Taken together, these results strongly highlight the need to con-
sider appropriate colloidal template sizes for the preparation of
polyelectrolyte templated PSiNPs used in cancer targeting applica-
tions to ensure that the cell targeting moieties are retained on the
surface of the final products. It is plausible that to obtain larger
monodisperse PSiNPs that retain the surface presentation and
hence functional properties of each polyelectrolyte used in the
PECs, correspondingly larger colloidal templates would need to
be used in the synthesis.3.8. Enhanced anticancer efficacy in patient-derived glioblastoma cells
The anticancer drug delivery potential of the Arg/PAA-PSiNPs
with combined tumour targeting and pH-responsiveness was
demonstrated using patient derived GBM1 cells. The enhanced
tumour cell uptake and increased Dox release in acidic pH environ-
ments such as the weakly acidic endosomes following cellular
internalisation effectively led to a significantly reduced half maxi-
mal inhibitory concentration (IC50) of 5.3 mM with Dox-loaded Arg/
PAA-PSiNPs compared to 14.0 mM of NH4OH/PAA-PSiNPs (Fig. 9) in
cell viability assays. The observed IC50 value of Dox-loaded Arg/
PAA-PSiNPs equates to 13.2 mg/mL of empty Arg/PAA-PSiNPs,
which is a concentration previously shown to induce minimal or
no toxicity in GBM1 cells (Fig. 7B). This result clearly demonstrates
that the enhanced anticancer effect seen with Dox-loaded Arg/
PAA-PSiNPs was due to the anticancer drug released and not a
result of PSiNP induced toxicity. The higher IC50 value observed
with Dox-loaded Arg/PAA-PSiNP compared to free Dox (1.8 mM)
can be explained by the slower drug release, where only approxi-
mately 30% of the loaded Dox was released from the Arg/PAA-
PSiNPs after 24 h (Fig. 6B). In spite of this result, the strong tumour
cell selectivity and pH-responsiveness of the Arg/PAA-PSiNPs are
expected to be more advantageous to promote in vivo tumour
accumulation of the Dox-loaded Arg/PAA-PSiNPs, where enhanced
Dox release can occur in response to the acidic tumour microenvi-
ronment and in the endosomes following uptake by tumour cells.4. Conclusion
Advancing from previously reported protocols [11,20], we have
introduced a versatile means to obtain highly uniform sub-100 nm
PSiNPs with readily tunable sizes using colloidally stable
Arg/PAA PECs as soft templates for silane mineralisation. We first
Fig. 9. Cell viability of GBM1 cells following 24 h treatment with Dox-loaded Arg/
PAA-PSiNPs and NH4OH-PSiNPs as determined using the WST-1 assay. The dotted
lines indicate the IC50 values. The results represent mean ± standard deviation from
two independent experiments performed with six replicates.
G. Newham, R.K. Mathew, H. Wurdak et al. Journal of Colloid and Interface Science 584 (2021) 669–683demonstrated that the strong electrostatic interactions between
Arg with PAA not only improved PEC uniformity compared to NH4-
OH/PAA PECs, and enabled fine control of the template diameter,
but also led to greatly increased porosity in the PSiNPs without
the need for template removal. The retention of PAA in the porous
network considerably enhanced the loading and pH responsive
release of anticancer therapeutic Dox. Additionally, Arg acted as a
basic catalyst and capping agent in the hydrolysis and condensa-
tion of silane precursors leading to facile surface functionalisation
of the PSiNPs during synthesis. We subsequently demonstrated
that the relationship between the volume of added silane and
the PEC template size could readily control the particle diameter
and monodispersity, and was further used to vary the surface pre-
sentation of cancer-targeting molecule, Arg. The selective uptake
and tumoricidal activity of Dox-loaded Arg/PAA-PSiNPs were suc-
cessfully demonstrated using primary patient-derived GBM cells
in comparison with non-tumorigenic neural progenitor cells. Taken
together, this readily scalable one-pot synthesis method of obtain-
ing highly uniform sub-100 nm PSiNPs with desirable properties
such as pH sensitivity and cancer cell targeting, without the need
for lengthy post-synthetic conjugation procedures, is expected to
offer both time and cost savings over currently used methods in
large-scale production. Furthermore, as the enhanced uptake of
Arg is common amongst aggressive malignancies, the Arg/PAA-
PSiNPs have potential to be used for in vivo drug delivery applica-
tions in a wide range of other cancer types.CRediT authorship contribution statement
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